Morgan Stanley analyst Bob Huang maintained a Buy rating on Progressive (PGR – Research Report) today and set a price target of $310.00.
Patients with severe forms of MS had encouraging results with a autologous hematopoietic stem cell transplantation in a large-scale real-world cohort.
The MS-STAT2 trial of a high-dose simvastatin has failed to slow progression of disability in patients with secondary ...
Secondary imaging endpoints generally were in the same direction as the primary endpoint. Plasma levels of NfL ... in people ...
Drugmakers had hoped that inhibiting receptor-interacting protein kinase would decrease inflammation and reduce neuronal degeneration in patients with multiple sclerosis and other neurodegenerative co ...
There are signs that society is moving away from the progressive left’s often strict expectations about how to discuss ...
California voters appear poised to reject several progressive ballot measures this November, suggesting a change to the state's liberal posture that could influence downballot Congressional races ...
“Little research has been done to characterize severe progressive MS, in part because there is no consensus on the exact definition and classification of this disease phenotype, no specific management ...
The “godfather of progressive prosecutors” has been in ... has pumped millions into GOP causes, and during the primary, Hochman hired fundraisers that raised money for Trump in 2020.
Progressive offers multiple types of insurance, including property coverage for homeowners. You can get a quote through its HomeQuote Explorer tool — the company lets you bundle your home and ...
A study published in the Journal of Biological Chemistry found a plant-derived flavonoid—a type of chemical compound—called sulfuretin blocked the activity of an enzyme involved in MS and cancer.
“Little research has been done to characterize severe progressive MS, in part because there is no consensus on the exact definition and classification of this disease phenotype, no specific management ...